Author's posts
'Frustrated with where we are': Massachusetts governor talks Steward troubles, plan of action
Massachusetts Gov. Maura Healey and her administration further addressed Steward Health Care’s financial troubles along with the state’s ongoing plan of action during a state public health council meeting Feb. 14.
AdventHealth buys Florida property for over $5M
Altamonte Springs, Fla.-based AdventHealth has purchased vacant property in Sanford, Fla., for around $5.3 million, the Orlando Business Journal reported Feb. 13.
Harvard gets $1.2M to develop oral antibiotics that kill drug-resistant infections
Harvard University researchers have received $1.2 million from CARB-X, a Boston University-led nonprofit that funds projects that focus on drug-resistant bacteria named on the CDC’s Antibiotic Resistant Threats list.
Congressman optimistic Medicare reimbursement cuts will be reversed
Indiana Rep. Larry Bucshon, MD, told the American Hospital Association that Medicare reimbursement cuts could be at least partially reversed in Congress’ next spending package, Roll Call reported Feb. 13.
Where employers are struggling the most, least with hiring
West Virginia ranked as the state where employers are having the hardest time finding workers, according to an analysis by WalletHub, a personal finance website.
Why 3 health systems ended RCM partnerships
Becker’s has reported on three health systems that have ended RCM partnerships since Aug. 4. Here is why the health systems cut those ties:
Central Maine Healthcare hospital names VP of nursing, patient services
Central Maine Healthcare has named Jenifer Madore vice president of nursing and patient services at its Rumford (Maine) Hospital.
FDA sends warning letters to vendors selling unapproved weight loss drugs
The FDA has sent warning letters to two online vendors — US Chem Labs and Helix Chemical Supply — for selling unapproved and misbranded versions of semaglutide and tirzepatide.
'Healthcare is not poker': Leader dives deeper into Steward's struggles
Alan Sager, PhD, professor of health law, policy and management and director of the health reform program at Boston University School of Public Health, has been conducting research on hospital closures for years.
Discontinued asthma drug stirs frustrations
After GSK discontinued its brand-name asthma drug Flovent on Jan. 1, families and physicians are struggling to access its generic solution, CNN reported Feb. 13.
